Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

European Innovation Council · Ended early

Heart Function Support Innovative, minimally invasive device to support the natural movement of the heart in heart failure patients

Coordinator
Syntach AB, Sweden
Runs
1 September 2022 to 31 March 2027
Status
Ended early
EU funding
€2.5m
Total cost
€25.7m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190120429

What the project is doing

In the project's own words, from its summary on CORDIS.

Syntach CS is a groundbreaking, life-saving device for long-term cardiac support that restores the natural function of the heart’s mitral plane movement in patients suffering from left ventricular heart failure. The technology is based on recent findings of the physiological movement of the intact heart, which pumps with a scooping, longitudinal movement of the mitral valve. In heart failure, this movement is impaired and the heart is unable to pump enough blood to meet the metabolic needs of the body.

Syntach CS works in synchronization with the heart, supports the cardiac movements and reestablishes a natural, healthy movement. It is fully implantable in a minimally invasive procedure. Heart movement support is enabled thanks to a mitral anchor ring connected to a drive unit implanted in the lower apex region of the heart from which a pulsatile movement is transferred to the mitral plane. The system is recharged and monitored wirelessly with no elements protruding through the skin.

Topics

Who is involved

OrganisationCityCountryRole
Syntach ABLundSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI